146 related articles for article (PubMed ID: 16622267)
21. [Expression of thymidine phosphorylase in primary colorectal cancer and liver metastasis-relationship between mRNA levels in cancer cells and protein levels in cancerous tissue].
Ishibashi K; Sobajima J; Ishiguro T; Okada N; Miyazaki T; Yokoyama M; Ishida H
Gan To Kagaku Ryoho; 2009 Mar; 36(3):425-9. PubMed ID: 19295266
[TBL] [Abstract][Full Text] [Related]
22. [Hepatic lymph node involvement in patients with synchronous multiple liver metastases of colorectal cancer].
Ishibashi K; Ohsawa T; Yokoyama M; Ishizuka N; Miyazaki T; Nakada H; Gonda T; Ishida H
Gan To Kagaku Ryoho; 2006 Nov; 33(12):1834-7. PubMed ID: 17212121
[TBL] [Abstract][Full Text] [Related]
23. Combined expression of the non-receptor protein tyrosine kinases FAK and Src in primary colorectal cancer is associated with tumor recurrence and metastasis formation.
de Heer P; Koudijs MM; van de Velde CJ; Aalbers RI; Tollenaar RA; Putter H; Morreau J; van de Water B; Kuppen PJ
Eur J Surg Oncol; 2008 Nov; 34(11):1253-61. PubMed ID: 18556171
[TBL] [Abstract][Full Text] [Related]
24. Eotaxin-2 and colorectal cancer: a potential target for immune therapy.
Cheadle EJ; Riyad K; Subar D; Rothwell DG; Ashton G; Batha H; Sherlock DJ; Hawkins RE; Gilham DE
Clin Cancer Res; 2007 Oct; 13(19):5719-28. PubMed ID: 17908961
[TBL] [Abstract][Full Text] [Related]
25. The gene expression profile represents the molecular nature of liver metastasis in colorectal cancer.
Yamasaki M; Takemasa I; Komori T; Watanabe S; Sekimoto M; Doki Y; Matsubara K; Monden M
Int J Oncol; 2007 Jan; 30(1):129-38. PubMed ID: 17143521
[TBL] [Abstract][Full Text] [Related]
26. CC chemokine ligand 7 expression in liver metastasis of colorectal cancer.
Cho YB; Lee WY; Choi SJ; Kim J; Hong HK; Kim SH; Choi YL; Kim HC; Yun SH; Chun HK; Lee KU
Oncol Rep; 2012 Aug; 28(2):689-94. PubMed ID: 22614322
[TBL] [Abstract][Full Text] [Related]
27. Messenger RNA expression of TS and ERCC1 in colorectal cancer and matched liver metastasis.
Kobayashi H; Sugihara K; Uetake H; Higuchi T; Yasuno M; Enomoto M; Iida S; Azuma M; Mori R; Omori A; Lenz HJ; Danenberg KD; Danenberg PV
Int J Oncol; 2008 Dec; 33(6):1257-62. PubMed ID: 19020759
[TBL] [Abstract][Full Text] [Related]
28. Expression and role of CCR6/CCL20 chemokine axis in pulmonary sarcoidosis.
Facco M; Baesso I; Miorin M; Bortoli M; Cabrelle A; Boscaro E; Gurrieri C; Trentin L; Zambello R; Calabrese F; Cassatella MA; Semenzato G; Agostini C
J Leukoc Biol; 2007 Oct; 82(4):946-55. PubMed ID: 17615381
[TBL] [Abstract][Full Text] [Related]
29. Prediction of prognosis and surgical indications for pulmonary metastasectomy from colorectal cancer.
Iizasa T; Suzuki M; Yoshida S; Motohashi S; Yasufuku K; Iyoda A; Shibuya K; Hiroshima K; Nakatani Y; Fujisawa T
Ann Thorac Surg; 2006 Jul; 82(1):254-60. PubMed ID: 16798225
[TBL] [Abstract][Full Text] [Related]
30. MMP-1 (collagenase-1) expression in primary colorectal cancer and its metastases.
Bendardaf R; Buhmeida A; Ristamäki R; Syrjänen K; Pyrhönen S
Scand J Gastroenterol; 2007 Dec; 42(12):1473-8. PubMed ID: 17852862
[TBL] [Abstract][Full Text] [Related]
31. High epidermal growth factor receptor expression in metastatic colorectal cancer lymph nodes may be more prognostic of poor survival than in primary tumor.
Deng Y; Kurland BF; Wang J; Bi J; Li W; Rao S; Lan P; Lin T; Lin E
Am J Clin Oncol; 2009 Jun; 32(3):245-52. PubMed ID: 19451802
[TBL] [Abstract][Full Text] [Related]
32. Detection and functional analysis of tumor infiltrating T-lymphocytes (TIL) in liver metastases from colorectal cancer.
Wagner P; Koch M; Nummer D; Palm S; Galindo L; Autenrieth D; Rahbari N; Schmitz-Winnenthal FH; Schirrmacher V; Büchler MW; Beckhove P; Weitz J
Ann Surg Oncol; 2008 Aug; 15(8):2310-7. PubMed ID: 18521684
[TBL] [Abstract][Full Text] [Related]
33. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
[TBL] [Abstract][Full Text] [Related]
34. Cancer/testis antigens and clinical risk factors for liver metastasis of colorectal cancer: a predictive panel.
Chen Z; Li M; Yuan Y; Wang Q; Yan L; Gu J
Dis Colon Rectum; 2010 Jan; 53(1):31-8. PubMed ID: 20010347
[TBL] [Abstract][Full Text] [Related]
35. Hypoxia in relation to vasculature and proliferation in liver metastases in patients with colorectal cancer.
van Laarhoven HW; Kaanders JH; Lok J; Peeters WJ; Rijken PF; Wiering B; Ruers TJ; Punt CJ; Heerschap A; van der Kogel AJ
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):473-82. PubMed ID: 16242253
[TBL] [Abstract][Full Text] [Related]
36. Clinical implications of fibroblast activation protein in patients with colon cancer.
Henry LR; Lee HO; Lee JS; Klein-Szanto A; Watts P; Ross EA; Chen WT; Cheng JD
Clin Cancer Res; 2007 Mar; 13(6):1736-41. PubMed ID: 17363526
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients.
Ottaiano A; Franco R; Aiello Talamanca A; Liguori G; Tatangelo F; Delrio P; Nasti G; Barletta E; Facchini G; Daniele B; Di Blasi A; Napolitano M; Ieranò C; Calemma R; Leonardi E; Albino V; De Angelis V; Falanga M; Boccia V; Capuozzo M; Parisi V; Botti G; Castello G; Vincenzo Iaffaioli R; Scala S
Clin Cancer Res; 2006 May; 12(9):2795-803. PubMed ID: 16675573
[TBL] [Abstract][Full Text] [Related]
38. [Prognostic analysis of 220 colorectal cancer patients with synchronous liver metastases].
He YF; Li YH; Zhang DS; Xiang XJ; Xu RH; Pan ZZ; Zhou ZW; Jiang WQ; He YJ; Wan DS
Ai Zheng; 2006 Sep; 25(9):1153-7. PubMed ID: 16965661
[TBL] [Abstract][Full Text] [Related]
39. Serum concentration of Reg IV in patients with colorectal cancer: overexpression and high serum levels of Reg IV are associated with liver metastasis.
Oue N; Kuniyasu H; Noguchi T; Sentani K; Ito M; Tanaka S; Setoyama T; Sakakura C; Natsugoe S; Yasui W
Oncology; 2007; 72(5-6):371-80. PubMed ID: 18187959
[TBL] [Abstract][Full Text] [Related]
40. Circulating gelatinases and tissue inhibitor of metalloproteinase-1 in colorectal cancer metastatic liver disease.
Waas ET; Wobbes T; Ruers T; Lomme RM; Hendriks T
Eur J Surg Oncol; 2006 Sep; 32(7):756-63. PubMed ID: 16650961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]